MSD and Daiichi Sankyo have revealed some of the clinical data that prompted them to start pivotal testing of ifinatamab deruxtecan (I-DXd) in patients with previously treated, extensive-stage ...
After hours: March 11 at 6:40:04 p.m. EDT Loading Chart for HEI ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback